BCL9L has previously been identified as a key mediator of aneuploidy tolerance in colorectal cancer, promoting genomic instability and tumor progression [43], a feature already recognized as a poor prognostic marker across several cancer types [44]. This evidence concerns the gene BCL9L and neoplasm.